tradingkey.logo
搜尋
市場行情
新聞
分析
交易工具
選股工具
投資課堂
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜尋

Collplant Biotechnologies Ltd

CLGN
添加自選
0.440USD
+0.020+4.79%
收盤 05/15, 16:00（美東）報價延遲15分鐘
6.34M總市值
虧損本益比TTM

Collplant Biotechnologies Ltd

0.440
+0.020+4.79%
概覽財務分析公司

概覽

財務

分析

公司

關於 Collplant Biotechnologies Ltd 公司

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Collplant Biotechnologies Ltd簡介

公司代碼CLGN
公司名稱Collplant Biotechnologies Ltd
上市日期Sep 01, 1993
CEORotem (Eran)
員工數量57
證券類型Ordinary Share
年結日Sep 01
公司地址4 Oppenheimer Street
城市REHOVOT
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編7670104
電話972732325600
網址https://www.collplant.com
公司代碼CLGN
上市日期Sep 01, 1993
CEORotem (Eran)

Collplant Biotechnologies Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q2
FY2024
FY2024Q2
FY2023
FY2023Q2
FY2022
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Revenues from licensing agreement
2.00M
84.35%
Revenues from the sales of goods
371.00K
15.65%
地區USD
名稱
營收
佔比
United States
2.18M
91.78%
Europe
98.00K
4.13%
Canada
96.00K
4.05%
Israel
1.00K
0.04%
業務
地區
業務USD
名稱
營收
佔比
Revenues from licensing agreement
2.00M
84.35%
Revenues from the sales of goods
371.00K
15.65%

股東統計

更新時間: 5月9日 週六
更新時間: 5月9日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Sagy (Ami)
11.36%
Loewenbaum (George Walter II)
8.71%
St. Denis J. Villere & Company, LLC
4.21%
Pinnacle Associates Ltd.
3.82%
Loewenbaum (Lilian Shaw)
2.82%
其他
69.08%
持股股東
持股股東
佔比
Sagy (Ami)
11.36%
Loewenbaum (George Walter II)
8.71%
St. Denis J. Villere & Company, LLC
4.21%
Pinnacle Associates Ltd.
3.82%
Loewenbaum (Lilian Shaw)
2.82%
其他
69.08%
股東類型
持股股東
佔比
Individual Investor
26.88%
Investment Advisor/Hedge Fund
4.72%
Investment Advisor
4.47%
Hedge Fund
1.51%
Research Firm
0.13%
Family Office
0.12%
Venture Capital
0.10%
Bank and Trust
0.01%
其他
62.05%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
35
1.89M
13.14%
-218.89K
2025Q4
34
1.82M
18.05%
--
2025Q3
36
1.82M
18.09%
-351.44K
2025Q2
36
2.17M
13.51%
+569.42K
2025Q1
36
2.09M
19.82%
-180.41K
2024Q4
38
2.54M
24.36%
-57.22K
2024Q3
40
2.59M
23.16%
+143.75K
2024Q2
40
2.45M
24.33%
+72.69K
2024Q1
40
2.38M
24.25%
-401.71K
2023Q4
45
2.39M
26.23%
-101.34K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Sagy (Ami)
1.64M
11.36%
-306.10K
-15.75%
Nov 19, 2025
Loewenbaum (George Walter II)
1.26M
8.71%
--
--
Nov 06, 2025
St. Denis J. Villere & Company, LLC
607.30K
4.21%
+18.58K
+3.16%
Dec 31, 2025
Pinnacle Associates Ltd.
557.19K
3.87%
+50.00K
+9.86%
Dec 31, 2025
Loewenbaum (Lilian Shaw)
406.29K
2.82%
-245.19K
-37.64%
Nov 06, 2025
Evans (Hugh M)
377.43K
2.62%
-1.00
-0.00%
Mar 15, 2025
AMH Equity, Ltd.
200.00K
1.39%
+39.15K
+24.34%
Sep 30, 2025
Brown Advisory
118.73K
0.82%
--
--
Dec 31, 2025
Pathstone
17.00K
0.12%
--
--
Dec 31, 2025
Tal (Yehiel)
31.14K
0.22%
--
--
Mar 15, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI